发明名称 Oral suspension of prednisolone acetate
摘要 Disclosed is a pharmaceutical composition for oral delivery, comprising a pharmaceutically effective amount of prednisolone acetate particles dispersed in suspension in the composition, wherein the composition is suitable for oral delivery and wherein the prednisolone acetate has a median particle size in the range of about 1 microns to about 30 microns. Also disclosed is the use of said composition in the treatment of endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases, allergic states, respiratory diseases, hemaologic disorders, neoplastic diseases, edema, gastrointestinal diseases or nervous diseases.
申请公布号 NZ566117(A) 申请公布日期 2011.06.30
申请号 NZ20060566117 申请日期 2006.08.03
申请人 TARO PHARMACEUTICALS NORTH AMERICA, INC. 发明人 ASOTRA, SATISH;GAO, SHEN;YACOBI, AVRAHAM
分类号 A61K9/00;A61K9/14;A61K31/56 主分类号 A61K9/00
代理机构 代理人
主权项
地址